Dominovas Energy Corp (OTCMKTS:DNRG) Shares Tick Higher on Appointment

0
297

Dominovas Energy Corp (OTCMKTS:DNRG) shares were up 5% on Monday to $0.00210 and flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.14. The company has a market cap of $553,712.00 at 237.30 million shares outstanding.

Dominovas Energy Corp is an exploration-stage company whose plan of operation is to seek for opportunities in the green and renewable energy industry. It has acquired 100% of Dominovas Energy LLC., which has completed the development of an electric power generating Fuel Cell System.

In a press release on Monday, Dominovas Energy Corp announced the appointment of Dr. Emma Rasolovoahangy as Ambassador for Renewable Energy Projects and Special Advisor for the Republic of Madagascar. She will assume responsibility for Dominovas Energy’s sub-Saharan renewable energy projects immediately.

“We are truly excited to welcome Dr. Emma to the Dominovas Energy team. Her technical expertise and her intellectual prowess as a highly acclaimed scientist, along with her industry knowledge, respect and recognition around the globe as one of the best in the field, and with her unyielding love for her native country of the Republic of Madagascar and unique in-country perspective, collectively makes her a truly invaluable addition to the Dominovas Energy team. We are quite fortunate to have someone of her caliber join us,” remarked Dominovas Energy Corp CEO Neal Allen.

Dr. Emma, as she is affectionately known to the Dominovas team, has also expressed excitement about joining the company. She mentioned that she is also optimistic about the strength of the team, its technologies, and the opportunities to make an impact in improving the lives of people in the sub-Saharan area. Dr. Emma will report to Michael Watkins, Chief Operating Officer of Dominovas Energy.

DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.